List of Tables
Table 1. Global Alzheimers and Parkinsons Diseases Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Alzheimers
Table 3. Key Players of Parkinsons
Table 4. Global Alzheimers and Parkinsons Diseases Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Alzheimers and Parkinsons Diseases Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Alzheimers and Parkinsons Diseases Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Alzheimers and Parkinsons Diseases Market Share by Region (2019-2024)
Table 8. Global Alzheimers and Parkinsons Diseases Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Alzheimers and Parkinsons Diseases Market Share by Region (2025-2030)
Table 10. Alzheimers and Parkinsons Diseases Market Trends
Table 11. Alzheimers and Parkinsons Diseases Market Drivers
Table 12. Alzheimers and Parkinsons Diseases Market Challenges
Table 13. Alzheimers and Parkinsons Diseases Market Restraints
Table 14. Global Alzheimers and Parkinsons Diseases Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Alzheimers and Parkinsons Diseases Market Share by Players (2019-2024)
Table 16. Global Top Alzheimers and Parkinsons Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimers and Parkinsons Diseases as of 2023)
Table 17. Ranking of Global Top Alzheimers and Parkinsons Diseases Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Alzheimers and Parkinsons Diseases Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Alzheimers and Parkinsons Diseases Product Solution and Service
Table 21. Date of Enter into Alzheimers and Parkinsons Diseases Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Alzheimers and Parkinsons Diseases Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Alzheimers and Parkinsons Diseases Revenue Market Share by Type (2019-2024)
Table 25. Global Alzheimers and Parkinsons Diseases Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Alzheimers and Parkinsons Diseases Revenue Market Share by Type (2025-2030)
Table 27. Global Alzheimers and Parkinsons Diseases Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Alzheimers and Parkinsons Diseases Revenue Market Share by Application (2019-2024)
Table 29. Global Alzheimers and Parkinsons Diseases Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Alzheimers and Parkinsons Diseases Revenue Market Share by Application (2025-2030)
Table 31. North America Alzheimers and Parkinsons Diseases Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Alzheimers and Parkinsons Diseases Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Alzheimers and Parkinsons Diseases Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Alzheimers and Parkinsons Diseases Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Alzheimers and Parkinsons Diseases Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Alzheimers and Parkinsons Diseases Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Alzheimers and Parkinsons Diseases Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Alzheimers and Parkinsons Diseases Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Alzheimers and Parkinsons Diseases Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Alzheimers and Parkinsons Diseases Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Alzheimers and Parkinsons Diseases Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Alzheimers and Parkinsons Diseases Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Alzheimers and Parkinsons Diseases Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Alzheimers and Parkinsons Diseases Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Alzheimers and Parkinsons Diseases Market Size by Country (2025-2030) & (US$ Million)
Table 46. Hoffmann-La Roche Company Detail
Table 47. Hoffmann-La Roche Business Overview
Table 48. Hoffmann-La Roche Alzheimers and Parkinsons Diseases Product
Table 49. Hoffmann-La Roche Revenue in Alzheimers and Parkinsons Diseases Business (2019-2024) & (US$ Million)
Table 50. Hoffmann-La Roche Recent Development
Table 51. Novartis Company Detail
Table 52. Novartis Business Overview
Table 53. Novartis Alzheimers and Parkinsons Diseases Product
Table 54. Novartis Revenue in Alzheimers and Parkinsons Diseases Business (2019-2024) & (US$ Million)
Table 55. Novartis Recent Development
Table 56. Pfizer Company Detail
Table 57. Pfizer Business Overview
Table 58. Pfizer Alzheimers and Parkinsons Diseases Product
Table 59. Pfizer Revenue in Alzheimers and Parkinsons Diseases Business (2019-2024) & (US$ Million)
Table 60. Pfizer Recent Development
Table 61. Merck Company Detail
Table 62. Merck Business Overview
Table 63. Merck Alzheimers and Parkinsons Diseases Product
Table 64. Merck Revenue in Alzheimers and Parkinsons Diseases Business (2019-2024) & (US$ Million)
Table 65. Merck Recent Development
Table 66. Eli Lilly Company Detail
Table 67. Eli Lilly Business Overview
Table 68. Eli Lilly Alzheimers and Parkinsons Diseases Product
Table 69. Eli Lilly Revenue in Alzheimers and Parkinsons Diseases Business (2019-2024) & (US$ Million)
Table 70. Eli Lilly Recent Development
Table 71. Orion Pharma Company Detail
Table 72. Orion Pharma Business Overview
Table 73. Orion Pharma Alzheimers and Parkinsons Diseases Product
Table 74. Orion Pharma Revenue in Alzheimers and Parkinsons Diseases Business (2019-2024) & (US$ Million)
Table 75. Orion Pharma Recent Development
Table 76. UCB Company Detail
Table 77. UCB Business Overview
Table 78. UCB Alzheimers and Parkinsons Diseases Product
Table 79. UCB Revenue in Alzheimers and Parkinsons Diseases Business (2019-2024) & (US$ Million)
Table 80. UCB Recent Development
Table 81. AstraZeneca Company Detail
Table 82. AstraZeneca Business Overview
Table 83. AstraZeneca Alzheimers and Parkinsons Diseases Product
Table 84. AstraZeneca Revenue in Alzheimers and Parkinsons Diseases Business (2019-2024) & (US$ Million)
Table 85. AstraZeneca Recent Development
Table 86. Biogen Company Detail
Table 87. Biogen Business Overview
Table 88. Biogen Alzheimers and Parkinsons Diseases Product
Table 89. Biogen Revenue in Alzheimers and Parkinsons Diseases Business (2019-2024) & (US$ Million)
Table 90. Biogen Recent Development
Table 91. Teva Pharmaceutical Industries Company Detail
Table 92. Teva Pharmaceutical Industries Business Overview
Table 93. Teva Pharmaceutical Industries Alzheimers and Parkinsons Diseases Product
Table 94. Teva Pharmaceutical Industries Revenue in Alzheimers and Parkinsons Diseases Business (2019-2024) & (US$ Million)
Table 95. Teva Pharmaceutical Industries Recent Development
Table 96. AbbVie Company Detail
Table 97. AbbVie Business Overview
Table 98. AbbVie Alzheimers and Parkinsons Diseases Product
Table 99. AbbVie Revenue in Alzheimers and Parkinsons Diseases Business (2019-2024) & (US$ Million)
Table 100. AbbVie Recent Development
Table 101. Vertical Pharmaceuticals Company Detail
Table 102. Vertical Pharmaceuticals Business Overview
Table 103. Vertical Pharmaceuticals Alzheimers and Parkinsons Diseases Product
Table 104. Vertical Pharmaceuticals Revenue in Alzheimers and Parkinsons Diseases Business (2019-2024) & (US$ Million)
Table 105. Vertical Pharmaceuticals Recent Development
Table 106. ALLERGAN Company Detail
Table 107. ALLERGAN Business Overview
Table 108. ALLERGAN Alzheimers and Parkinsons Diseases Product
Table 109. ALLERGAN Revenue in Alzheimers and Parkinsons Diseases Business (2019-2024) & (US$ Million)
Table 110. ALLERGAN Recent Development
Table 111. ACADIA Pharmaceuticals Company Detail
Table 112. ACADIA Pharmaceuticals Business Overview
Table 113. ACADIA Pharmaceuticals Alzheimers and Parkinsons Diseases Product
Table 114. ACADIA Pharmaceuticals Revenue in Alzheimers and Parkinsons Diseases Business (2019-2024) & (US$ Million)
Table 115. ACADIA Pharmaceuticals Recent Development
Table 116. Impax Laboratories Company Detail
Table 117. Impax Laboratories Business Overview
Table 118. Impax Laboratories Alzheimers and Parkinsons Diseases Product
Table 119. Impax Laboratories Revenue in Alzheimers and Parkinsons Diseases Business (2019-2024) & (US$ Million)
Table 120. Impax Laboratories Recent Development
Table 121. GE healthcare Company Detail
Table 122. GE healthcare Business Overview
Table 123. GE healthcare Alzheimers and Parkinsons Diseases Product
Table 124. GE healthcare Revenue in Alzheimers and Parkinsons Diseases Business (2019-2024) & (US$ Million)
Table 125. GE healthcare Recent Development
Table 126. VTV Therapeutics Company Detail
Table 127. VTV Therapeutics Business Overview
Table 128. VTV Therapeutics Alzheimers and Parkinsons Diseases Product
Table 129. VTV Therapeutics Revenue in Alzheimers and Parkinsons Diseases Business (2019-2024) & (US$ Million)
Table 130. VTV Therapeutics Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Alzheimers and Parkinsons Diseases Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Alzheimers and Parkinsons Diseases Market Share by Type: 2023 VS 2030
Figure 3. Alzheimers Features
Figure 4. Parkinsons Features
Figure 5. Global Alzheimers and Parkinsons Diseases Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Alzheimers and Parkinsons Diseases Market Share by Application: 2023 VS 2030
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Other Case Studies
Figure 10. Alzheimers and Parkinsons Diseases Report Years Considered
Figure 11. Global Alzheimers and Parkinsons Diseases Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Alzheimers and Parkinsons Diseases Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Alzheimers and Parkinsons Diseases Market Share by Region: 2023 VS 2030
Figure 14. Global Alzheimers and Parkinsons Diseases Market Share by Players in 2023
Figure 15. Global Top Alzheimers and Parkinsons Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimers and Parkinsons Diseases as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Alzheimers and Parkinsons Diseases Revenue in 2023
Figure 17. North America Alzheimers and Parkinsons Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Alzheimers and Parkinsons Diseases Market Share by Country (2019-2030)
Figure 19. United States Alzheimers and Parkinsons Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Alzheimers and Parkinsons Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Alzheimers and Parkinsons Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Alzheimers and Parkinsons Diseases Market Share by Country (2019-2030)
Figure 23. Germany Alzheimers and Parkinsons Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Alzheimers and Parkinsons Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Alzheimers and Parkinsons Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Alzheimers and Parkinsons Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Alzheimers and Parkinsons Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Alzheimers and Parkinsons Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Alzheimers and Parkinsons Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Alzheimers and Parkinsons Diseases Market Share by Region (2019-2030)
Figure 31. China Alzheimers and Parkinsons Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Alzheimers and Parkinsons Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Alzheimers and Parkinsons Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Alzheimers and Parkinsons Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Alzheimers and Parkinsons Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Alzheimers and Parkinsons Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Alzheimers and Parkinsons Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Alzheimers and Parkinsons Diseases Market Share by Country (2019-2030)
Figure 39. Mexico Alzheimers and Parkinsons Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Alzheimers and Parkinsons Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Alzheimers and Parkinsons Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Alzheimers and Parkinsons Diseases Market Share by Country (2019-2030)
Figure 43. Turkey Alzheimers and Parkinsons Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Alzheimers and Parkinsons Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Hoffmann-La Roche Revenue Growth Rate in Alzheimers and Parkinsons Diseases Business (2019-2024)
Figure 46. Novartis Revenue Growth Rate in Alzheimers and Parkinsons Diseases Business (2019-2024)
Figure 47. Pfizer Revenue Growth Rate in Alzheimers and Parkinsons Diseases Business (2019-2024)
Figure 48. Merck Revenue Growth Rate in Alzheimers and Parkinsons Diseases Business (2019-2024)
Figure 49. Eli Lilly Revenue Growth Rate in Alzheimers and Parkinsons Diseases Business (2019-2024)
Figure 50. Orion Pharma Revenue Growth Rate in Alzheimers and Parkinsons Diseases Business (2019-2024)
Figure 51. UCB Revenue Growth Rate in Alzheimers and Parkinsons Diseases Business (2019-2024)
Figure 52. AstraZeneca Revenue Growth Rate in Alzheimers and Parkinsons Diseases Business (2019-2024)
Figure 53. Biogen Revenue Growth Rate in Alzheimers and Parkinsons Diseases Business (2019-2024)
Figure 54. Teva Pharmaceutical Industries Revenue Growth Rate in Alzheimers and Parkinsons Diseases Business (2019-2024)
Figure 55. AbbVie Revenue Growth Rate in Alzheimers and Parkinsons Diseases Business (2019-2024)
Figure 56. Vertical Pharmaceuticals Revenue Growth Rate in Alzheimers and Parkinsons Diseases Business (2019-2024)
Figure 57. ALLERGAN Revenue Growth Rate in Alzheimers and Parkinsons Diseases Business (2019-2024)
Figure 58. ACADIA Pharmaceuticals Revenue Growth Rate in Alzheimers and Parkinsons Diseases Business (2019-2024)
Figure 59. Impax Laboratories Revenue Growth Rate in Alzheimers and Parkinsons Diseases Business (2019-2024)
Figure 60. GE healthcare Revenue Growth Rate in Alzheimers and Parkinsons Diseases Business (2019-2024)
Figure 61. VTV Therapeutics Revenue Growth Rate in Alzheimers and Parkinsons Diseases Business (2019-2024)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed